Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2762 |
|
| Actual shortage: | 228 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2524 (91%) | |
Discontinuation Reports |
256 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 253 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
13 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2022-02-10 | 2022-05-19 | 154723 |
| TEVA-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-09-23 | 2022-05-19 | 146098 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2022-04-28 | 2022-05-06 | 159596 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-24 | 2022-05-05 | 157265 |
| TEVA-LENOLTEC NO. 4 | 60MG 300MG | TABLET | Resolved | 2022-03-24 | 2022-05-05 | 157259 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Resolved | 2021-12-02 | 2022-05-05 | 150406 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-09-02 | 2022-04-28 | 145127 |
| TEVA-FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-07-29 | 2022-04-28 | 143236 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-06-24 | 2022-04-28 | 141480 |
| ACT PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137905 |
| ACT PIOGLITAZONE | 15MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137882 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2022-03-24 | 2022-04-21 | 157262 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2022-03-04 | 2022-04-21 | 156058 |
| TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-02-24 | 2022-04-21 | 155563 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2022-02-17 | 2022-04-21 | 155180 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2022-02-17 | 2022-04-21 | 155174 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-02-17 | 2022-04-21 | 155149 |
| TEVA-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-02-17 | 2022-04-21 | 155134 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-01-20 | 2022-04-21 | 153165 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-01-20 | 2022-04-21 | 153156 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14052 |
| TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |